Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy

Clinical trial NCT00551265 · WITHDRAWN

Trial details

NCT number: NCT00551265
Sponsor: Gynecologic Oncology Group
Status: WITHDRAWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Fallopian Tube Carcinoma Primary Peritoneal Carcinoma Recurrent Ovarian Carcinoma Stage III Ovarian Cancer Stage IV Ovarian Cancer

Start date: 2007-10-01
Primary completion: 2009-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.